首页> 外国专利> TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-.ALPHA. FUNCTION

TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-.ALPHA. FUNCTION

机译:使用抗TNF-α药物治疗与肥胖相关的II型糖尿病的胰岛素抵抗。功能

摘要

An induction of TNF-.alpha. mRNA expression has been observed in adipose tissue from four different insulin resistant rodent models of obesity and diabetes. TNF-.alpha. protein was also elevated locally and systemically. Neutralization of TNF-.alpha. in obese fa/ fa rats caused a significant increase in the peripheral uptake of glucose in response to insulin. A method of treating an animal suffering from insulin resistance in obesity linked Type II diabetes mellitus is disclosed. The method includes providing a therapeutic agent that includes an antagonist to TNF-.alpha. function in a pharmaceutically acceptable carrier substance and administering a pharmacologically effective amount of the therapeutic agent to the animal.
机译:TNF-α的诱导。在肥胖和糖尿病的四种不同的胰岛素抵抗性啮齿动物模型的脂肪组织中已观察到mRNA表达。 TNF-α蛋白质也在局部和全身升高。中和TNF-α。在肥胖fa / fa大鼠中,胰岛素引起的外周葡萄糖摄取显着增加。公开了治疗与肥胖相关的II型糖尿病的胰岛素抵抗的动物的方法。该方法包括提供包含TNF-α拮抗剂的治疗剂。在药学上可接受的载体物质中发挥功能,并向动物施用药理学有效量的治疗剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号